Tamibarotene(Ohara)

他米巴罗汀(Ohara)

Report date: 2025/10/24 17:59:38

Base Information

Drug NameTamibarotene(Ohara)
Drug Alias NameOP-09
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptor alpha agonistsRetinoic acid receptor beta agonists
TargetsRetinoic acid receptor alphaRetinoic acid receptor beta
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOhara Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A